Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NREF
3901
NexPoint Real Estate Finance
NREF
$320M
| $340K | ﹤0.01% |
21,730
+8,002
| +58% | +$120K |
|
3902
Biglari Holdings Class B
BH
$1.25B
| $340K | ﹤0.01% |
1,974
+869
| +79% | +$158K |
|
3903
Pangaea Logistics
PANL
$498M
| $339K | ﹤0.01% |
46,899
+34,273
| +271% | +$237K |
|
3904
CALL
Plug Power
PLUG
$2.87B
| $339K | ﹤0.01% |
150,000
-570,000
| -79% | -$1.28M |
|
3905
Alto Neuroscience
ANRO
$1.05B
| $339K | ﹤0.01% |
29,599
+26,556
| +873% | +$325K |
|
3906
ReposiTrak
TRAK
$153M
| $339K | ﹤0.01% |
18,333
+5,744
| +46% | +$105K |
|
|
IMA
3907
ImageneBio Inc
IMA
$63M
| $338K | ﹤0.01% |
16,276
-61
| -0.4% | -$1.23K |
|
3908
CALL
Pliant Therapeutics
PLRX
$64.4M
| $336K | ﹤0.01% |
30,000
-30,000
| -50% | -$375K |
|
|
3909
PUT
Pliant Therapeutics
PLRX
$64.4M
| $336K | ﹤0.01% |
+30,000
| New | +$375K |
|
3910
Lifezone Metals
LZM
$309M
| $336K | ﹤0.01% |
48,032
+35,253
| +276% | +$247K |
|
3911
Genie Energy
GNE
$367M
| $335K | ﹤0.01% |
20,617
+14,455
| +235% | +$236K |
|
3912
Park Aerospace
PKE
$737M
| $335K | ﹤0.01% |
25,710
+19,213
| +296% | +$255K |
|
|
EARN
3913
Ellington Residential Mortgage REIT
EARN
$162M
| $334K | ﹤0.01% |
+47,919
| New | +$333K |
|
3914
Primis Financial Corp
FRST
$399M
| $334K | ﹤0.01% |
27,441
+19,460
| +244% | +$230K |
|
3915
Information Services Group
III
$199M
| $334K | ﹤0.01% |
101,111
+34,816
| +53% | +$114K |
|
3916
Lyell Immunopharma
LYEL
$317M
| $332K | ﹤0.01% |
12,031
+9,116
| +313% | +$268K |
|
|
PBPB
3917
DELISTED
Potbelly
PBPB
| $332K | ﹤0.01% |
39,780
+28,342
| +248% | +$216K |
|
3918
Natural Gas Services Group
NGS
$472M
| $331K | ﹤0.01% |
17,301
+5,575
| +48% | +$111K |
|
3919
Nokia
NOK
$51B
| $331K | ﹤0.01% |
75,651
+2,106
| +3% | +$8.52K |
|
3920
CALL
Autodesk
ADSK
$49.5B
| $331K | ﹤0.01% |
1,200
-46,000
| -97% | -$11.6M |
|
3921
Nathan's Famous
NATH
$402M
| $330K | ﹤0.01% |
4,084
+2,984
| +271% | +$222K |
|
3922
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$800M
| $329K | ﹤0.01% |
10,200
| – | – |
|
3923
Sibanye-Stillwater
SBSW
$6.26B
| $329K | ﹤0.01% |
+80,000
| New | +$339K |
|
3924
Emergent Biosolutions
EBS
$373M
| $328K | ﹤0.01% |
39,308
+30,792
| +362% | +$280K |
|
3925
Prime Medicine
PRME
$527M
| $328K | ﹤0.01% |
84,697
+65,593
| +343% | +$304K |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.